Latest News & Features
Americas
AstraZeneca’s research development arm MedImmune has revealed plans to spin out six molecules into an independent biotech company. 6 March 2018
Americas
Mylan has revealed plans to develop and commercialise a proposed biosimilar to Botox. 6 March 2018
Big Pharma
The UK’s Prime Minister has revealed that the UK would be willing to remain part of the European Medicines Agency after Brexit. 5 March 2018
Americas
Swiss-based pharmaceutical company Helsinn Healthcare has filed a petition for writ of certiorari with the US Supreme Court. 5 March 2018
Americas
The Saint Regis Mohawk Tribe and Allergan are planning to appeal against the Patent Trial and Appeal Board’s decision rejecting tribal sovereign immunity. 2 March 2018
Europe
The EU General Court has dismissed a request to revoke a syringe trademark on the grounds of non-use, partially affirming the initial decision of the Cancellation Division. 1 March 2018
Americas
DowDuPont, a specialist in agriculture, materials science and speciality products, has revealed the names of three independent companies that it intends on creating. 1 March 2018
Americas
Late last week, the Patent Trial and Appeal Board rejected a Native American tribe’s attempt to dismiss inter partes reviews based on the tribe’s sovereign immunity claims. 1 March 2018
Americas
The US Food and Drug Administration has introduced a pilot scheme for processing orphan designation requests more efficiently, as part of its commitment to support and expedite the development of rare disease products. 28 February 2018
Big Pharma
The European Patent Office will hear an opposition against a patent covering Mylan’s EpiPen at the end of March. 27 February 2018